‍ ‍

Green Tea Extract: Research

Overview

‍ ‍

This page provides a curated overview of selected peer‑reviewed scientific studies examining green tea extract, a concentrated botanical preparation derived from the leaves of Camellia sinensis, the plant traditionally used to produce green tea. The goal of this page is to provide transparent access to commonly cited research in the scientific literature. The summaries below describe findings reported in published studies. They are presented for educational purposes as part of a clinician‑led review of the scientific literature.

Important Context for Readers

Scientific studies examine outcomes in defined populations under specific research conditions. Results reported in individual studies may not apply to all individuals, and findings should not be interpreted as guaranteed outcomes. This page summarizes selected research examining green tea extract and green tea catechins, including epigallocatechin gallate (EGCG), the most extensively studied catechin found in green tea. It is not intended to provide medical advice, diagnosis, or treatment recommendations. This page is provided for educational purposes and does not include product recommendations or affiliate links.

Summary of Evidence

‍Green tea extract has been evaluated extensively in randomized controlled trials, systematic reviews, and meta-analyses. Research has primarily focused on glucose metabolism, lipid biomarkers, blood pressure, body composition, oxidative balance, and safety.

Across pooled analyses, green tea extract has generally demonstrated modest but consistent effects on selected cardiometabolic biomarkers under study conditions. However, findings vary substantially according to catechin content, EGCG concentration, formulation, dose, study duration, and population characteristics.

‍Key Areas of Research

Metabolic Support

Evidence strength: Moderate.

‍1) Liu K, Zhou R, Wang B, et al. Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. American Journal of Clinical Nutrition. 2013.

PMID: 23803878

DOI:https://doi.org/10.3945/ajcn.112.052746

Population: Adults across 17 randomized controlled trials.

Design: Meta-analysis.

Key Findings:
• Fasting glucose decreased by approximately 0.09 mmol/L under study conditions
• HbA1c decreased by approximately 0.30% under study conditions
• High-quality studies demonstrated reductions in fasting insulin concentrations
• Findings supported modest improvements in glucose metabolism under study conditions

2) Xu R, Bai Y, Yang K, et al. Effects of green tea consumption on glycemic control: a systematic review and meta-analysis of randomized controlled trials. Nutrition & Metabolism. 2020.

PMID: 32190104

DOI: https://doi.org/10.1186/s12986-020-00469-5

Population: Adults across randomized controlled trials.

Design: Systematic review and meta-analysis.

Key Findings:
• Improvements in selected glucose-related biomarkers were reported under study conditions
• Findings generally supported modest metabolic benefits
• Considerable heterogeneity remained across included studies
• Results highlighted variability between formulations and study populations

3) Yu J, Song P, Perry R, et al. The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis. Diabetes & Metabolism Journal. 2017.

PMID: 28868822

DOI: https://doi.org/10.4093/dmj.2017.41.4.251

Population: Adults with type 2 diabetes or prediabetes.

Design: Systematic review and meta-analysis.

Key Findings:
• No significant improvements were observed for several major glycemic outcomes
• No significant improvements were observed for HbA1c, fasting insulin, or insulin resistance measures
• Results highlighted substantial heterogeneity across studies and formulations
• This study is important because it illustrates the inconsistent findings observed across portions of the green tea literature

Cardiovascular and Lipid Support         

‍Evidence strength: Moderate.

4) Zheng XX, Xu YL, Li SH, et al. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. American Journal of Clinical Nutrition. 2011.

PMID: 21715508

DOI: https://doi.org/10.3945/ajcn.110.010926

Population: Adults across 14 randomized controlled trials.

Design: Meta-analysis.

Key Findings:
• Total cholesterol decreased by approximately 7.2 mg/dL under study conditions
• LDL cholesterol decreased by approximately 2.2 mg/dL under study conditions
• HDL cholesterol was not significantly affected
• Effects appeared consistent across green tea beverage and extract studies

5) Zamani M, Rezaei Kelishadi M, Ashtary-Larky D, et al. The effects of green tea supplementation on cardiovascular risk factors: a systematic review and meta-analysis. Frontiers in Nutrition. 2023.

PMID: 36714735

DOI: https://doi.org/10.3389/fnut.2022.1084455

Population: Adults across randomized controlled trials.

Design: Systematic review and meta-analysis.

Key Findings:
• Improvements in LDL cholesterol, total cholesterol, and triglycerides were reported under study conditions
• Improvements in selected glucose-related biomarkers were observed
• Modest reductions in blood pressure were reported
• Effects varied according to dose, duration, and population characteristics

6) Neyestani TR, Nikooyeh. A Comprehensive Overview on the Effects of Green Tea on Anthropometric Measures, Blood Pressure, Glycemic and Lipidemic Status: An Umbrella Review and Meta-Meta-Analysis. Nutrition, Metabolism & Cardiovascular Diseases. 2022.

PMID: 35749363

DOI: https://doi.org/10.1016/j.numecd.2022.05.021

Population: Adults across multiple prior meta-analyses.

Design: Umbrella review and meta-meta-analysis.

Key Findings:
• Favorable effects were reported across multiple cardiometabolic biomarkers
• Improvements were observed in blood pressure, glucose, and lipid measures under study conditions
• Findings supported broader cardiometabolic effects of green tea consumption
• Authors noted substantial variability among included studies

Other Support

Evidence Strength: Low to Moderate

7) Zhong X, Zhang T, Liu Y, et al. Short-Term Weight-Centric Effects of Tea or Tea Extract in Patients with Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials. Nutrition & Diabetes. 2015.

PMID: 26075637

DOI: https://doi.org/10.1038/nutd.2015.10

Population: Adults with metabolic syndrome.

Design: Meta-analysis.

Key Findings:
• Modest reductions in body weight were observed under study conditions
• Waist circumference improved modestly
• Effects were generally small but statistically significant
• Findings suggest that green tea may contribute modestly to body composition outcomes within broader lifestyle strategies

8) Jürgens TM, Whelan AM, Killian L, et al. Green Tea for Weight Loss and Weight Maintenance in Overweight or Obese Adults. Cochrane Database of Systematic Reviews.

PMID: 23235664

DOI: https://doi.org/10.1002/14651858.CD008650.pub2

Population: Overweight and obese adults.

Design: Cochrane systematic review.

Key Findings:
• Weight-loss effects were generally small
• Findings were not considered clinically meaningful for most individuals
• Green tea did not significantly improve long-term weight-loss maintenance
• This review provides an important counterbalance to more optimistic weight-management claims

9) Asbaghi O, Rezaei Kelishadi M, Ashtary-Larky D, et al. Effects of Green Tea Extract Supplementation on Body Composition, Obesity-Related Hormones and Oxidative Stress Markers: A Systematic Review and Dose-Response Meta-Analysis. British Journal of Nutrition. 2024.

PMID: 38031409

DOI: https://doi.org/10.1017/S000711452300260X

Population: 59 randomized controlled trials involving 3,802 participants.

Design: Systematic review and dose-response meta-analysis.

Key Findings:
• Body mass decreased significantly under study conditions
• Body mass index decreased significantly under study conditions
• Body fat percentage decreased significantly under study conditions
• Total antioxidant capacity increased significantly
• Malondialdehyde, a marker of oxidative stress, decreased significantly
• Findings suggest possible effects on body composition and oxidative balance pathways

‍Safety

Evidence Strength: Moderate

10) Isomura T, Suzuki S, Origasa H, et al. Liver-Related Safety Assessment of Green Tea Extracts in Humans: A Systematic Review of Randomized Controlled Trials. European Journal of Clinical Nutrition. 2016.

PMID: 27188915

DOI: https://doi.org/10.1038/ejcn.2016.78

Population: Adults across randomized controlled trials evaluating green tea extracts.

Design: Systematic review.

Key Findings:
• Green tea extract was generally well tolerated under study conditions
• Rare liver-related adverse events were reported
• Risk appeared influenced by dose, formulation, and fasting administration
• Most participants completed supplementation without serious adverse events

11) Sarma DN, Barrett ML, Chavez ML, et al. Safety of Green Tea Extracts: A Systematic Review by the U.S. Pharmacopeia. Drug Safety. 2008.

PMID: 18484782

DOI: https://doi.org/10.2165/00002018-200831060-00003

Population: Published human case reports and clinical literature.

Design: Systematic safety review.

Key Findings:
• Identified rare cases of hepatotoxicity associated with concentrated green tea extracts
• Risk appeared uncommon but clinically important
• Findings contributed to modern safety recommendations regarding high-dose green tea extract use
• The review helped establish awareness of liver-related safety considerations for concentrated green tea products

Educational Notice
These summaries are provided for educational purposes to review published scientific literature and should not be interpreted as medical advice, diagnosis, or treatment recommendations. Readers should consult qualified healthcare professionals for personal medical decisions.

‍FDA Disclaimer
These statements have not been evaluated by the U.S. Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.

‍FTC Affiliate Disclosure
‍Some pages on this website may contain affiliate links to products. If readers choose to purchase through those links, the site may receive a commission. Affiliate relationships do not influence the selection or discussion of scientific studies summarized on this reference page.